Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Key Takeaways Phentermine is a short-term appetite suppressant, while Saxenda (liraglutide) is designed for long-term weight management and healthier eating habits
Global GLP-1 Receptor Agonist Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Semaglutide, Dulaglutide, Liraglutide, Exenatide), By Type (Victoza, Ozempic, Saxenda, Trulicity, Bydureon), By Application (Type 2 Diabetes, Obesity, and Others), By Route of Administration (Parenteral and Oral), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 2032 Industry: Healthcare Global GLP-1 Receptor Agonist Market Insights Forecasts to 2032 The Global GLP-1 Receptor Agonist Market Size was valued at USD 13.4 Billion in 2022
J Pain (2017) 18(4):359.e1359.e38
Some peptides are considered investigational and are not FDA approved
US$ 22.22
US$ 22.70
US$ 28.10
US$ 29.92
